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Nifedipine  and  atenolol  dugs  are  conjugated  in  several  anti-hypertensive  pharmaceutical  formulations.
Herein,  a reproducible  and  sensitive  voltammetric  procedure  has  been  developed  for the  simultaneous
analysis  of nifedipine  and  atenolol  for the  ﬁrst  time  using  MgO − nanoplatelets  modiﬁed  screen-
printed  electrodes  (MgO  − SPEs)  via  differential  pulse  voltammetry  (DPV).  Two  very  well-resolved
and  reproducible  signals/oxidation  peaks  with  a voltammetric  separation  of 0.35  V were  obtained  in
Britton–Robinson  (BR)  buffer  (pH  9). The  MgO  NPLs  are  found  to  exhibit  a high  electrocatalytic  activity  and
improved  voltammetric  response  compared  to unmodiﬁed  (bare)  SPEs.  Under  optimum  pH  conditionstenolol
agnesium oxide
creen-printed electrodes
ntihypertensive
anoparticles
(pH  9),  the  DPV  curves  exhibit  linear  responses  to  nifedipine  and  atenolol  over the  concentration  ranges
of  0.2–104.41  M and  6.66–909.09  M with  detection  limits  of  0.032  M  and  1.76 M,  respectively.  The
applicability  of the  MgO-SPEs  is successfully  utilized  for simultaneous  determination  of nifedipine  and
atenolol  in  pharmaceutical  tablets  and  human  urine  samples  with  good  accuracy  and  precision,  these
epend
ublisresults  agreeing  with  ind
©  2017  The  Authors.  P
. Introduction
Hypertension is the most prevalent cardiovascular disease in
he world and affects as many as one quarter of the global adult
opulation. Hypertension is an independent risk factor for stroke
nd coronary heart diseases [1]. The etiopathogenesis of hyperten-
ion is multifactorial; hence, several classes of anti-hypertensive
rugs have been explored. To efﬁciently control high blood pressure
evels, the use of antihypertensive combination drugs with com-
lementary mechanism of actions has been markedly increased;
herefore improving treatment compliance and adhesion have
een performed rather than employing monotherapy [2] as rec-
mmended by the 2009 reappraisal of the European Society [3].
alcium channel blockers and ß-blockers are complementary and
heir combination in lower concentration levels showed signiﬁ-
antly blood pressure reduction compared to the maximum doses
∗ Corresponding authors.
E-mail addresses: mohamed.khairy@science.sohag.edu.eg (M. Khairy),
.banks@mmu.ac.uk (C.E. Banks).
ttp://dx.doi.org/10.1016/j.snb.2017.06.105
925-4005/© 2017 The Authors. Published by Elsevier B.V. This is an open access article 
/).ent  high-performance  liquid  chromatography  (HPLC).
hed  by  Elsevier  B.V.  This  is  an  open  access  article  under the  CC  BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
of each ingredient [4]. Nifedipine (NIF) and atenolol (ATN) are a
common combination to control high blood pressure [5,6]. NIF is a
calcium channel blocker described as 3, 5- dimethyl 2,6-dimethyl-
4-(2-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate and has
commonly been used as a potent arterial vasodilator in the
management of angina and cardiovascular diseases [7]. ATN
is a beta-1 blocker chemically designed as (RS)-4-(2-hydroxy-
3-isopropylaminopropoxy) phenylacetamide and is a primarily
therapeutic drug for treatment of different cardiovascular disor-
ders, such as cardiac arrhythmia and myocardial infarction [8].
These drugs combinations require highly restricted quality control
in order to control alterations in their bioavailability and potency
in vivo. Therefore, quantiﬁcation of each active ingredient without
the effect of interferences is highly recommended [9].
Various analytical techniques have been used for the determina-
tion of NIF and ATN separately such as spectrophotometry [10,11],
spectroﬂuorimetry [12], chemilumeniscence [13] and voltamme-
try [14–21]. Lei Xu et al. have developed capillary electrophoretic
methods with amperometric detection for the determination of
ATN in urine samples [22]. The UV absorption spectra of NIF and
ATN overlap precluding their simultaneous [23]. Therefore, the
under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.
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nalysts are turning to use the derivative and derivative ratio spec-
rophotometric methods for simultaneous determination of NIF
nd ATN. These methods show low signal, poor sensitivity, in-
onvenient signal-to-noise ratio, poor robustness and susceptibly
o potential interferences form excipients. Many chromatographic
ethods have been reported for simultaneous quantiﬁcation of NIF
nd ATN, however, high-cost, lack of portability, complex sam-
le pre-treatment requirements, and inability to perform rapid
n-ﬁeld measurements limit their applicability [23–25]. For exam-
le, ATN was determined voltammetrically using bare/unmodiﬁed
oron diamond doped electrodes (BDE) [14], carbon paste elec-
rodes (CPE) modiﬁed with mordenite-type zeolite [17], amino
cids assembly on gold nanoparticles (NPs) modiﬁed glassy car-
on electrodes (GCE) [18], BiVO4–Bi2O3/ITO electrodes [15] and
uO nanoparticle modiﬁed CPEs [19]. NIF was also determined by
g NPs/GCE [20], Pd/Ag NPs alloy modiﬁed graphene nanoribbons
16] and ˇ-cyclodextrin modiﬁed multi-walled carbon nanotube
aste electrode [21]. Although these electrodes offered high selec-
ivity for quantiﬁcation of a single drug molecule, the continuous
olishing, surface fouling, poisoning with time and decrease their
ensitivity and reproducibility are still required; there is still an
nmet need for a disposable, potentially portable electrochemical
ased sensing system which allows simultaneous determination of
TN and NIF drugs.
Nanomaterials have recently become one of the most exciting
orefront ﬁeld in analytical chemistry because they offer high effec-
ive surface-to-volume ratio, a unique ability to promote electron
ransfer, high catalytic efﬁciency and control over local microen-
ironment [26,27]. Therefore, nanomaterials acting as “electronic
ires” to enhance the electron transfer between redox centres in
he analyte and electrode surfaces [28]. Magnesium oxide (MgO)
s a nontoxic, low-cost semiconductor [29], its optical band gap is
bout 5.40 eV [30]. MgO  has large medicinal applications such as
rug delivery, cell signalling and imaging and as a potent antimi-
robial and antioxidant against resistant dreadful diseases [31,32].
nterestingly, magnesium ions change the bioavailability of NIF and
TN drugs and thus might interact with both anti-hypertensive
rugs [33].
Herein, a simple and large-scale production of MgO  NPLs has
een developed via a gentle hydrothermal treatment of MgCl2
ithin basic medium (pH 10). MgO  NPLs have been dispersed and
mmobilised upon SPEs and utilized for the simultaneous determi-
ation of NIF and ATN in pharmaceutical tablets and urine samples.
o the best of our knowledge, no study has been reported to date
pon the simultaneous voltammetric determination of NIF and ATN
n pharmaceutical formulations or biological ﬂuids. Interestingly
PEs have inherent advantages such as miniaturization, versatility,
ow cost and the possibility of mass production [34]. Hence, simple
odiﬁcation of SPEs by MgO  NPLs shows a simple, rapid, accurate,
nd validated analytical method for simultaneous quantiﬁcation
f NIF and ATN combination in pharmaceutical tablets Tenolat SR
®
nd human ﬂuids. The MgO-SPEs are independently validated using
PLC.
. Experimental section
.1. Reagents and materials
All chemicals were of the highest analytical grade available
nd were used as received without further puriﬁcation from
igma-Aldrich Company. All solutions were prepared using dou-
ly distilled water of resistivity no less than 18.2 M cm.  NIF was
indly supplied by Sigma Pharmaceutical Co. (6th of October 2016,
gypt) and its purity value was (98.21 ± 1.22). ATN was kindly sup-
lied by El Kahira Pharmaceutical Co. (6th of October, Egypt) and itsors B 252 (2017) 1045–1054
purity value was (98.67 ± 1.54). Tenolat SR® (Sigma pharmaceuti-
cal Co., Cairo, Egypt) was labelled to contain 20.0 mg  NIF and 50 mg
ATN per tablet. The pharmaceutical formulations were purchased
from local market. Solutions of Britton Robinson (B.R.) buffer of a
wide pH range from 2 to 11 were prepared for the further studies.
2.2. Synthesis of MgO nanoplatelets (NPLs)
The synthesis of MgO  NPLs was carried out by utilizing a typical
hydrothermal procedure via hydrolysis of MgCl2 (2.033 g dissolved
in 50.0 mL  water) in basic medium at pH 10. The solution was
introduced into a 100.0 mL  Teﬂon-lined, stainless steel autoclave.
The autoclave was sealed and maintained at 160 ◦C for 12 h. The
as-prepared white precipitate was collected and washed several
times with water/ethanol mixture. The white precipitate was dried
overnight at 45 ◦C and then calcined at 300 ◦C for 3 h.
2.3. Fabrication of screen-printed electrodes (SPEs)
The screen-printed graphite electrodes were fabricated at
Manchester Metropolitan University utilizing appropriate stencil
designs with a microDEK 1760RS screen-printing machine (DEK,
Weymouth, UK) [35–38]. For each of the screen-printed sensors
a carbon–graphite ink formulation (Product Code: product code:
C2000802P2; Gwent Electronic Materials Ltd, UK) was ﬁrst screen-
printed onto a polyester ﬂexible ﬁlm (Autostat, 250 m thickness).
This layer was cured in a fan oven at 60 ◦ Celsius for 30 min. Next
a silver/silver chloride (40:60) reference electrode was applied by
screen-printing Ag/AgCl paste (Product Code: C2040308P2; Gwent
Electronic Materials Ltd, UK) onto the plastic substrate. This layer
was once more cured in a fan oven at 60 ◦ Celsius for 30 min. Last
a dielectric paste ink (Product Code: D2070423P5; Gwent Elec-
tronic Materials Ltd, UK) was  printed to cover the connections and
deﬁne the 3 mm diameter graphite working electrode. After curing
at 60 ◦ Celsius for 30 min  the screen-printed electrode is ready to
use. Similar screen-printed platforms have been electrochemically
characterized in a previous contribution [35–38].
2.4. Preparation of MgO-SPEs and electrochemical measurements
Typically, 5 mg  of MgO  NPLs was mixed with 100 L of 1% poly-
tetraﬂuoroethylene (PTFE) and dispersed in 50 mL  of deionized
water for 30 min. 5 L of this suspension was  dropped onto the SPEs
dried for one hour at 50 ◦C in the oven before the electrochemical
experiments.
2.5. Characterization of MgO NPLs
The morphology of the MgO  sample was  investigated using
ﬁeld emission scanning electron microscopy (FE-SEM, JEOL model
6500). The MgO  powder was ground and ﬁxed onto a specimen stub
using double-sided carbon tape. To obtain high-resolution micro-
graphs, a 10 nm Pt ﬁlm was coated on the magnesium oxide using
anion sputtering (Hitachi E-1030) at room temperature. The SEM
was operated at 15 KeV to obtain high-resolution SEM images.
Wide-angle powder X-ray diffraction (XRD) was  performed by
X-ray diffractometer (Model FW 1700 series, Philips, Netherlands)
using with monochromatic Cu K radiation ( = 1.54 Å), employing
a scanning rate of 0.06◦/min and 2 ranges from 20◦ to 80◦. The
diffraction data were analysed using PDF software Released in 1996.
The voltammetric experiments were performed using Auto-
lab 302N potentiostat/galvanostat workstation. All measurements
were conducted using a three electrode conﬁguration.
Cyclic voltammetry (CV) of MgO-SPEs was performed in poten-
tial range from −1.0 to 0.8 V at scan rate of 50 mV/s in B. R. buffer
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Table 1
Simulation of impedance data via equivalent circuit model.
Parameters SPEs MgO-SPEs
R1/ 1000 1000
R2/k 19 10
AW1/ks-1/2 18 10
P1/F  2.5 2.0
n1  0.8 0.8M.  Khairy et al. / Sensors and 
olution of pH 9 until the electrochemical CV signal became stable.
he optimum parameters for differential pulse voltammetry mea-
urements are; deposition potential is − 0.5 V, deposition time is
 s, modulation amplitude is 0.07 V, modulation time is 0.05 s, and
tep potential is 0.005 V.
Chromatographic measurement was carried out on an
utochro-3000 HPLC system (Younglin, Korea) equipped with
V detector, Rheodyne injection valve with a 20 L loop. Mono-
ithic column RP-18e 100 mm × 4.6 mm (Merck, Darmstadt,
ermany) was employed for the separation. The mobile phase
omposed of (acetonitrile: 0.02 M phosphate buffer, pH = 4.0)
62.5: 37.5, v/v). The phosphate buffer was prepared by adding
0 mL  of triethylamine to the prepared buffer (0.01 M).  The pH
djusted using orthophosphoric acid. The mobile phase was
repared, ﬁltered through 0.45 m membrane ﬁlter and degassed
or 10 min  before use. The detection was carried out at wavelength
30 nm at ﬂow rate 1.2 mL/min.
.6. Applicability of MgO-SPEs for the determination of NIF and
TN in real samples
Ten tablets were accurately weighed and ﬁnely grinded in mor-
ar. A chosen amount of this powder equivalent to 30 mg  of NIF
nd 75 mg  ATN was transferred into a 25 mL  volumetric ﬂask.
bout 20 mL  of ethanol was added, swirled and sonicated for
 min. The volume of the sample was completed to the mark and
nally ﬁltered using ﬁne ﬁlter paper. The ﬁrst portion of the ﬁl-
rate was rejected. Speciﬁc volume of the drug stock solutions was
iluted with ethanol to obtain a suitable concentration within lin-
ar calibration plot. Standard addition method has been utilized for
etermination of NIF and ATN in tablet.
The urine samples were taken from healthy peoples in Sohag
niversity Hospital. All samples were diluted 30 times with BR
olution of pH 9 before DPV measurements. The accuracy of the
roposed DPV method was explored by spiking urine samples with
ifferent concentrations of NIF and ATN. The standard addition
ethod was used for recovery determination of NIF and ATN in
rine samples. The optimum conditions that was  employed using
P C18 column and mobile phase composed of (acetonitrile: 0.02 M
hosphate buffer, pH = 4.0) (62.5: 37.5, v/v). The detection was per-
ormed at wavelength 230 nm.
. Results and discussion
.1. Physical characterization of MgO  NPLs
The morphology of the MgO  samples, prepared as described in
he experimental section, was investigated using scanning electron
icroscopy (SEM). SEM images show a highly dispersed and uni-
orm hexagonal platelet-like morphology (Fig. 1a). The average size
f hexagonal platelet is found to corresponding to an average width
f ∼200 nm with a thickness of 30 nm.  Fig. 1b shows the XRD pat-
ern of MgO  sample. The diffraction peaks can be indexed to the
ubic lattice of MgO  (JCPDS No. 4-829), with the characteristic peaks
t (111), (200), (220), (311), and (222). This result indicates that the
gO  is in a pure crystalline material with no impurities.
.2. Electrochemical characterization of MgO-SPEs
The electrochemical performance of the MgO NPLs modi-
ed screen-printed electrodes (MgO-SPEs) have been investigated
nd directly compared to unmodiﬁed (graphite) screen-printed
lectrodes (SPEs) using cyclic voltammetry and electrochemical
mpedance spectroscopy. Fig. 2 shows the cyclic voltammograms
nd complex plan plots of 0.3 mM of potassium ferroyanide
4[Fe(CN)6] in 0.1 KCl using unmodiﬁed SPEs and MgO-SPEs. It isR1 is solution resistance, R2 is charge transfer resistance, AW1  is Warburg
impedance, P1 is capacitance and n1 takes value from 0 to 1.0 to describe the
constant phase element.
found that the potential peak separation corresponds to 412 mV
and 314 mV  at a scan rate of 50 mV (vs. Ag/AgCl) for the unmodi-
ﬁed SPEs and MgO-SPEs, respectively. In order to evaluate the effect
of MgO  NPLs upon the SPE’s heterogeneous electron transfer prop-
erties, it is possible to employ the Nicholson’s method [39]. It is
widely used to estimate the heterogeneous rate constant (k◦) for
quasi-reversible electrochemical reactions via the following equa-
tion:
 = ko{DnF/RT}−1/2
where  is a kinetic parameter, D is the diffusion coefﬁcient for
[Fe(CN)6]3−/4− (7.60 × 10−6 cm2 s−1), n is the number of electrons
transferred in the reaction,  is the scan rate, F is the faraday con-
stant, R is the gas constant, and T is the Temperature (Kelvin).
 is deduced from EP (the peak-to-peak separation) for a one
electron process at a set temperature (298 K). For practical usage,
the function of  (EP) could ﬁts Nicholson’s data as given by:
 = (−0.6288 + 0.0021X)/(1 − 0.017X), where X = EP is used to
determine  as a function of experimentally obtained EP values
at various voltammetric scan rates [40]. It is therefore possible to
produce a graph, whereby  is plotted against [DnF/RT]−1/2, and
the standard heterogeneous rate constant (k◦) can be determined
via the gradient. In cases where the EP exceeds a value of 212 mV,
the following equation should be considered:
k
◦ =
[
2.18
(
˛DnF/RT
)1/2]
Exp
[
−
(
˛2nF
RT
)
xEP
]
where  is assumed to be 0.5. The heterogeneous rate constants
were determined to be 8.21 × 10−4 and 1.72 × 10−3 cm s−1 for SPEs
and MgO-SPEs, respectively [40]. MgO  NPLs enhanced the electro-
chemical performance and facilitate the electron transfer rate of
the graphite screen-printed electrode in order of 2 times.
The complex plan plots of unmodiﬁed SPEs and MgO-SPEs in
K4[Fe(CN)6]/0.1 M KCl represented also the enhanced electrochem-
ical performance in presence of MgO  NPLs. The applied DC-voltage
is about 0.35 V (vs. Ag/AgCl), the excitation voltage applied to the
electrochemical cell was 5 mV  and the frequency range was from
100 kHz to 0.1 Hz. The Nyquist plots showed a semicircle followed
by straight line, which reveal direct electron transfer (Fig. 2b). The
simulation of the impedance spectra involved ohmic solution resis-
tance (R1), charge transfer resistance (R2), Warburg impedance
(W1) for diffusion of [Fe(CN)6]4− in KCl solution and P1 and n1 are
related to constant phase element (CPE) of a double layer capac-
itance. As shown in Table 1, the charge transfer resistance and
Warburg impedance were signiﬁcantly decreased conﬁrming an
effective an MgO-mediated charge transfer process at SPE surfaces.
3.3. Electrochemical behaviours of NIF and ATN using MgO  NPLsScreen-printing was utilized to fabricate economic, sensitive,
reproducible, portable and disposable electrochemical sensors,
which is advantageous since this approach offers online ﬁeld detec-
tion [35–38,40]. Different nanostructure materials such as BiO [41],
1048 M.  Khairy et al. / Sensors and Actuators B 252 (2017) 1045–1054
Fig. 1. SEM image (a) and XRD pattern (b) of the fabricated MgO  nanoplatelets.
Fig. 2. (a) Typical cyclic voltammetry curves and (b) complex plan plot of 0.3 mM K4[Fe(CN)6] in 0.1 M KCl at unmodiﬁed SPEs and MgO  − SPEs [Inset: The equivalent circuit
describes the electron transfer process at the two SPE surfaces].
F t in p
s
N
w
t
o
f
t
A
B
e
u
e
iig. 3. (A) DPV curves of 25 M NIF and 131 M ATN both simultaneously presen
tructures of NIF and ATN, respectively.
iO [42], CuO [36], ZnO [43], carbon nanotube (CNT) and MgO
ere investigated for determination of NIF and ATN. It was found
hat MgO  shows a promising nanostructure material for simultane-
us determination of NIF and ATN (Fig. S1 (a, b)). MgO  NPLs were
abricated as described in the experimental section. Fig. 3 shows
ypical differential pulse voltammograms of 25 M NIF and 131 M
TN comparing the response of unmodiﬁed SPEs and MgO-SPEs in
.R. buffer pH 9. The MgO-SPEs shows great improvement of the
lectrochemical response of NIF and ATN (Fig. 3) compared to the
nmodiﬁed/bare SPE indicating that the MgO  nanoplatelets offer
nhanced electron transfer characteristics.
The choice of a suitable medium/electrolyte is very important
n electroanalytical research since it is greatly inﬂuenced the ana-H 9 using (a) unmodiﬁed SPEs and (b) MgO  − SPEs. (B) and (C) are the chemical
lytical response of analytes. The electrochemical behaviours of NIF
and ATN have been studied using MgO-SPEs over a wide range of pH
values, namely, 2–11. Fig. S2 shows the electrochemical behaviours
of 66 M NIF and 322 M ATN on MgO-SPEs recorded in differ-
ent pH values. Generally, the pH dependence of the voltammetric
response shows an increase in the intensity of the anodic peak cur-
rent in basic buffer solutions for both drugs. ATN did not show any
electrochemical response below pH 6 due to the protonation of its
amino group [44]. The B.R. buffer solutions of pH 7 and pH 9 were
used to determine NIF and ATN, separately. Well-deﬁned voltam-
metric anodic peaks were presented at 0.49 V and 0.70 V for NIF
and ATN in pH 7 and pH 9, respectively. The difference in oxidation
peak potentials of NIF and ATN was about 0.35 V in pH 9 com-
M.  Khairy et al. / Sensors and Actuators B 252 (2017) 1045–1054 1049
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Fig. 4. CV curves of 66 M NIF (a) and 322 M ATN (b) in B.R. buffer solution using MgO  −SPEs in pH 7 and pH 9, respectively.
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rig. 5. DPV curves of NIF (a) and ATN (c) additions in B.R. buffer pH 7 and pH 9 res
TN  (d). [DPV parameters: Step potential = 0.005 mV,  modulation amplitude = 0.07 V
ared to 0.25 V in pH 7. Therefore, pH 9 was selected as suitable
H value to determine both NIF and ATN in pharmaceutical dosage
nd human ﬂuids. The oxidation peak potentials for NIF and ATN
hifted toward less positive values with increasing the solution pH,
ndicating protons participation in the electrochemical processes.
he slope of linear relationship between Ep and pH was  found to
e 51 mV/pH and 54 mV/pH for NIF and ATN, respectively. These
alues are very close to Nernstian slope (59 mV/pH at 298 K) for a
rocess that involves the transfer an equal number of protons and
lectrons in the electrochemical mechanism.
Fig. 4 shows the cyclic voltammetric curves of 66 M NIF (Fig. 4a)
nd 322 M ATN (Fig. 4b) in B.R. buffer solution pH 7 and pH
 respectively using MgO-SPEs over the range of scan rates 5 −
00 mV/s. The peak currents of NIF and ATN are found to increase
ith increasing voltammetric scan rates. As shown in Fig. S3, the
xidation peak current of NIF is linearly correlated with scan rates;
NIF /A = 0.92 (/Vs−1) − 38.51 A; R2 = 0.99. However, the oxidation
eak current of ATN is linearly correlated with square root of scan
ate; IATN /A = 0.36 (/Vs−1)0.5 + 22.55 A; R2 = 0.99. This behaviourely, linear correlation of oxidation peak current and concentrations of NIF (b) and
ulation time 0.05 s, interval time = 0.1s, scan rate = 0.05 mVs−1].
reveals that, the electrochemical oxidation of NIF is governed by
adsorption process while ATN is under a diffusion controlled pro-
cess. A small shift in the peak potential toward positive direction
was also observed which conﬁrms the irreversibility nature of the
electrode processes.
3.4. Determination of NIF and ATN using MgO-SPEs
The instrumental parameters in the DPV experiments such as
deposition potential, deposition time, modulation amplitude, mod-
ulation time, interval time and step potential have been optimized
in BR buffer solution (pH 9.0) containing the mixture of 16 M NIF
and 160 M of ATN. The optimum DVP parameters were found to
be: deposition potential,−0.5 V; deposition time, 5s; modulation
amplitude, 0.07 mV;  modulation time, 0.05 s; interval time, 0.1s;
scan rate, 0.05 mVs−1; and step potential 0.005 V. Fig. 5 shows
DPV curves for the consecutive additions of concentrations of NIF
over the range of 0.20 M − 104.41 M and ATN concentrations
over the range of 6.67–1660 M into B.R. buffer solution of pH
1050 M.  Khairy et al. / Sensors and Actuators B 252 (2017) 1045–1054
Table 2
Comparison of various voltammetric methods for independent determination of ATN and NIF with the previous works.
comment Refs. Supporting
electrolyte
Real
sample
LOD
(M)
Linear range
(M)
Drug Electrode
-Difﬁcult to apply inﬁeld
-Small linear concentration range
-Electrode Poisoning and fouling with time
[19] 0.15 M B. R.
Buffer
serum 1.12 12–96 ATN CuO NPs/CP
-Tedious fabrication process
-Difﬁcult to apply inﬁeld
-Expensive electrode materials
[15] 0.25 M NaNO3 Tablet
Urine
0.459 50 −800 ATN BiVO4–Bi2O3/ITO
-Small concentration range
-Electrode Poisoning and fouling with time
[17] Acetate buffer
pH5
Tablet
Urine
0.10 0.4 to 80 ATN 1 Mordenite/CP
-Tedious pre-treatment process
-Small linear concentration range
-Polishing is needed
-Electrode Poisoning with time
[14] 0.5 M
NaNO3–HNO3,
pH 1.0
Tablet 0.93 2.0 − 41 ATN BDE
-Multistep fabrication process
-Difﬁcult to apply in-ﬁeld
-Small linear concentration range
-Expensive electrode materials
-Polishing is needed
-Electrode Poisoning with time
[18] B.R. buffer pH 9.5 –– 0.39 1- 100 ATN poly(glutamic)
acid/cysteine/Au
NPs/GCE
-Tedious fabrication process
-Difﬁcult to apply in-ﬁeld
-Expensive electrode
-Polishing is needed
-Electrode Poisoning with time
[16] 0.1 M PBS (pH
7.0) + 10 mM
CTAB
Tablet 0.004 0.01 − 4 NIF 2 PdAg/graphene
nanoribbons/GCE
-Tedious fabrication process
-Difﬁcult to apply in-ﬁeld
-low stability
-Polishing is needed
[21] B.R. buffer pH 1.5 Tablet
Urine
0.015 0.048 −20 NIF -
cyclodextrin/MWCNT
-Tedious fabrication process
-Difﬁcult to apply in-ﬁeld
-Expensive electrode materials
-Polishing is needed
-Electrode Poisoning with time
[19] Tablet
Urine
0.72 0.8–60.0 NIF 3 Ag NPs/GCE
-Large scale electrode production
-Simple fabrication process
-Wide linear concentration range
-Reproducible and stable electrode in real
samples
-  disposable electrode
This work B.R. buffer pH 9 Tablet
Urine
1.76 6.67 − 909 ATN MgO-SPEs
0.032 0.2–104.4 NIF
N oped
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Ps: nanoparticles; MWCNT: multiwalled carbon nanotube; BDE: boron diamond d
 and pH 9 respectively. It can be seen that with increasing the
oncentrations of NIF and ATN, the oxidation peak heights were
inearly increased. The linear calibration plot of NIF (Fig. 5b) was
btained from the analysis voltammograms over concentration
ange of 0.20–104.41 M;  IP /A = 0.06CNIF /M + 0.21 A; R2 = 0.99;
 = 3. The analysis of the voltammetric peak current of ATN reveals
wo linear responses (Fig. 5d); IP (A) = 0.013CATN /M + 0.18 A;
2 = 0.993; N = 3 and IP (A) = 0.006CATN /M + 3.9 A; R2 = 0.99; N = 3.
ased on the standard deviation of the intercept and the average
lope of the linear calibration range, the limits of detection were
stimated to be 0.032 M and 1.76 M for NIF and ATN respec-
ively. To the best of our knowledge, NIF and ATN are conjugated
n several pharmaceutical formulations but there is no published
ork for simultaneous voltammetric determination of NIF and ATN
n tablets or biological ﬂuids (Table 2).
.5. Simultaneous determination of NIF and ATN using MgO-SPEs
Next, attention was turned to determination of NIF in pres-
nce of ATN. Fig. 6a shows the consecutive additions of NIF in
he range of 1.7 − 63 M in presence of 385 M ATN in B.R.
uffer pH 9. Interestingly, the oxidation peak current of ATN was
lmost constant with an RSD = 2.33%. The linear relationship of
eak current and NIF additions can be described as follows; IP
A) = 0.07CNIF /M + 0.047 A; R2 = 0.99; N = 3. Additions of ATN
oncentrations in the range of 33–1170 M in presence of 20 M
IF in B.R. buffer pH 9 is depicted in Fig. 6B. The oxidation electrode; CP: carbon past.
peak current of NIF was  remained constant with RSD = 1.09%. The
analysis of the peak height with concentration of ATN can be
presented as IP (A) = 0.0129CATN /M + 0.19 A; R2 = 0.996; N = 3
and IP (A) = 0.0048CATN /M + 4.6 A; R2 = 0.99; N = 3. These results
revealed that, there is no signiﬁcant interference from each analyte
in the simultaneous determination of its pairs. It is very important
to note that, the electrochemical oxidation processes of ATN and NIF
antihypertensive drugs are independent onto MgO- SPE. Further,
NIF and ATN were also determined by simultaneously changing
their concentrations in BR buffer solution of pH 9. Fig. 7 shows DPV
for continuous additions of both NIF and ATN unitizing MgO  NPLs as
nanozyme materials. The analysis of NIF voltammetric peak current
reveals a linear response (Fig. 7b) in range of 1.3–101 M with cor-
responding calibration equation; IP (A) = 0.063CNIF /M + 0.13 A;
R2 = 0.994; N = 3. On other hand, the analysis of ATN voltammet-
ric peak current represents also a linear response (Fig. 7c) over
the range of 6.67–500 M;  IP (A) = 0.0125CATN /M + 0.067 A;
R2 = 0.99; N = 3. As shown, MgO-SPEs show promising electrode
material for simultaneous determination of NIF and ATN because
they offered sensitivity, stability, reproducibility, and economical
compared with previous literatures (Table 2).
3.6. Accuracy, repeatability and robustness of MgO-SPEsThe DPV method was validated according to ICH [45] guidelines
2005 and complied with USP [46] on the validation of analytical
methods. Accuracy is measured by adding known amounts of the
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Fig. 6. (a) DPV curves for additions of NIF in the presence of 385 M ATN, (b) additions of ATN in presence of 25 M NIF, Linear correlation of peak currents and concentrations
of  (c) NIF and (d) ATN in BR buffer solution of pH 9.0 using MgO  − SPEs.
Table 3
Accuracy of the proposed voltammetric method.
% Recovery ± SDa Total Amount Found [M] Amount Added [M]  Amount Taken [M] Drug
100. 59 ± 1.76 15.09 4.62 9.24 NIF
98.68 ± 1.76 19.74 9.24 9.24
98.83  ± 2.62 24.71 13.68 9.24
98.10  ± 2.55 3.75 15 30 ATN
98.37 ± 1. 92 19.67 30 30
101.05 ± 3.35 25.03 45 30
a Average of 6 determinations.
Table 4
Inter- and Intra-day precision of the proposed method.
Inter-day RSD% b Intraday RSD% a Conc. [M] Drug
2.76 2.06 0.33 NIF
1.98 1.51 15
2.72 2.96 39.51
2.34 1.56 6.62 ATN
0.67 1.08 100
2.89 2.31 866.1
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Table 5
Robustness of the proposed voltammetric method.
Recovery (%) ± SDa Experimental
parameter
ATN NIF
99.93 ± 1.96 99.67 ± 1.78 Optimal parameters
98.45 ± 1.56
100.98 ± 2.45
100.92 ± 0.98
98.78 ± 2.05
Starting Potential
−0.52
−0.48
97.96± 2.45
101.53 ± 1.58
98.67 ± 1.91
97.95 ± 2.21
Modulation Amplitude
0.0705
0.0695
98.67 ± 1.97
99.45 ± 2.25
98.31 ± 1.89
99.56 ± 1.65
Modulation Time
0.0495
0.0505
103.97 ± 2.79
98.15± 1.69
98.78 ± 0.83
101.41 ± 2.31
Step Potential
0.0495
0.0505
98.29 ± 1.88
97.64 ± 2.26
101.57 ± 1.46
98.19 ± 2.41
Interval Time
0.495a Average of 6 determinations.
b Average of 18 determinations over 3 days.
tandard NIF and ATN (at three concentration levels 50%, 100% and
50%) to pre-analysed tablet samples according to the ICH guide-
ines. After dilution of drugs to the recommended concentrations
f the investigated drugs, six separated solutions were analysed
y the proposed method. The results were obtained using standard
ddition protocol and they were satisfactory as indicated in Table 3.
he recovery experiments were carried out by adding 9.24 M and
0 M of NIF and ATN solutions prepared from commercial prod-
cts to 15.0 mL  of B. R buffer pH 9 followed by standard additions of
ach stock solutions. The recoveries of known amounts of NIF and
TN contained in pharmaceutical formulations are given in Table 3.
he estimated recoveries were ranged from 97.10% to 100.90%,
ndicating an acceptable accuracy of the DPV method.0.505
a Average of 3 determinations.Intra-day repeatability was  estimated by measurement of six
replicates of three concentration levels covering the low, medium,
and high concentration ranges of each calibration plot. Inter-day
1052 M.  Khairy et al. / Sensors and Actuators B 252 (2017) 1045–1054
Fig. 7. (a) DPV curves for the simultaneous determination of NIF and ATN in B.R. buffer pH 9, (b) linear correlation of oxidation peak current of NIF against its concentrations, (c)
linear  correlation of oxidation peak current of ATN against its concentration of ATN. [DPV parameters: Step potential = 0.005 mV, modulation amplitude = 0.07 V modulation
time  0.05 s, interval time = 0.1s, scan rate = 0.05 mVs−1].
Table 6
Application of the proposed voltammetric method for determination of the studied drugs in commercial tablets.
F-value t-value Recovery%± SDa HPLC [24] Recovery%± SDa Proposed method Dosage form (tablet)
1.32 1.75 97.22 ± 1.25 98.40 ± 1.08 NIF
NIF+ ATN (Tenolat SR)
1.23  0.38 98.13 ± 1.94 98.53 ± 1.75 ATN
Theoretical values at 95% conﬁdence limit; t = 2.30 F = 5.05.
a Average of six determinations.
M.  Khairy et al. / Sensors and Actuat
Table  7
Application of the proposed voltammetric method for determination of the studied
drugs in Urine sample.
Recovery% ± SDa Found conc. [M] Added conc. [M] Drug
92.56 ± 3.32 0.185 0.2 NIF
93.46 ± 1.97 4.67 5
91.69 ± 3.56 9.17 10
94.21 ± 3.74 6.283 6.67 ATN
95.41 ± 1.61 14.31 15
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a Average of six determinations.
ariation was evaluated due to measure drug repeatedly with the
ame concentration over a period of three days intra-day and
nter-day precision were expressed as percent relative standard
eviation (% RSD) the results were given in Table 4. For all con-
entration levels, the RSD didn’t exceed 2.96% indicating good
recision. The robustness of the analytical procedure is a measure of
ts capacity to remain unaffected by small but deliberate variation
n the method parameters and provide indication of its reliabil-
ty during normal usage. A small variation in the DPV method
arameters did not affect the voltammetric response signiﬁcantly
s shown in Table 5. This result indicates that, MgO-SPE showed
igh robustness for simultaneous determination of NIF and ATN in
eal samples.
.7. Analysis of real samples
The applicability of MgO-SPEs for simultaneous voltammetric
etermination of NIF and ATN in real samples has been explored in
 dosage form Tenolat SR tablet; containing 20 mg  NIF and 50 mg
TN and urine samples. Six replicate measurements have been per-
ormed for each concentration. The results have been depicted in
ables 6 and 7. Interestingly, the voltammetric methodology for
imultaneous determination of NIF and ATN by utilizing MgO-SPEs
how a satisfactory results compared with reported HPLC method.
o signiﬁcant difference was found by applying t- and F- tests at
5% conﬁdence level, indicating high accuracy, precision and suit-
bility of MgO-SPEs for sensitive determination of the NIF and ATN
ntihypertensive drugs simultaneously in pharmaceutical formu-
ations.
The recovery experiment for NIF and ATN in collected urine sam-
les have been performed by addition of 0.5 mL  of urine sample
o 14.5 mL  B.R. buffer pH 9. The spiked NIF and ATN concentra-
ions have been measured via standard addition protocol as shown
n Table 7. These results revealed that MgO-SPEs are a promising
lectrode for simultaneous determination of NIF and ATN in urine
atrix with excellent recoveries percentage.
. Conclusions
We  report, for the ﬁrst time, simultaneous voltammetric deter-
ination of NIF and ATN anti-hypertensive drugs by utilizing MgO
PLs modiﬁed SPEs. The studied drugs are formulated together in
ingle pharmaceutical dosage forms. The results have shown that
gO-SPEs are a promising disposable electrode for the fabrica-
ion of a highly sensitive electrochemical sensor for simultaneous
etection of NIF and ATN. The merits of the SPEs as the basis of
he sensor can be also taken into consideration such as: low cost,
asy construction and storage, potential for miniaturization, facility
f automation and construction of simple and portable equip-
ent. Furthermore, adequate recovery results were obtained for
he simultaneous determination of NIF and ATN in spiked human
rine sample, indicating that the proposed voltammetric method
an be applied to routine analysis.
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